Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma

Author(s):
Porta, C.; Osanto, S.; Ravaud, A.; Climent, M.A.; Vaishampayan, U.; White, D.A.; Creel, P.; Dickow, B.; Fischer, P.; Gornell, S.S.; Meloni, F.; Motzer, R.J.
Published
2011
Publication type
Article / Letter to editor
EverolimusRenal cell carcinomaAdverse eventsSafetyPatient management
Date issued
2011-06-30
Language
English
Is part of
European Journal of Cancer (2011), Vol. 47, no. 9, p. 1287-1298
hdl
1887/108751
doi
10.1016/j.ejca.2011.02.014